Bio-Techne Corporation (NASDAQ:TECH) has made a 20.01% comeback from a 12-month low price of $128.06. It was seen 3.18% higher, changing the price to $153.69, when the closing bell rang on 01/10/2019. At recent session, the prices were hovering between $147.42 and $154. This company shares are 22.08% off its target price of $187.63 and the current market capitalization stands at $5.79B. The recent change has given its price a -2.03% deficit over SMA 50 and -25.41% deficit over its 52-week high. The stock witnessed -1.25% declines, -18.48% declines and 1.03% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found TECH’s volatility during a week at 3.36% and during a month it has been found around 3.57%.Bio-Techne Corporation (TECH) Top Holders
Institutional investors currently hold around $5.29 billion or 96.5% in TECH stock. Look at its top three institutional owners. Blackrock Inc. owns $561.63 million in Bio-Techne Corporation, which represents roughly 9.7% of the company’s market cap and approximately 10.61% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 3,361,425 shares of the stock are valued at $500.72 million. The third largest holder is Brown Capital Management Llc, which currently holds $308.07 million worth of this stock and that ownership represents nearly 5.32% of its market capitalization.Bio-Techne Corporation 13F Filings
At the end of September reporting period, 146 institutional holders increased their position in Bio-Techne Corporation (NASDAQ:TECH) by some 2,974,550 shares, 183 decreased positions by 3,072,840 and 52 held positions by 29,482,142. That puts total institutional holdings at 35,529,532 shares, according to SEC filings. The stock grabbed 44 new institutional investments totaling 632,635 shares while 43 institutional investors sold out their entire positions totaling 843,631 shares.Bio-Techne Corporation (NASDAQ:TECH) Insider Trades
Multiple company employees have indulged in significant insider trading. Bio-Techne Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Baumgartner Robert V has sold 5,000 shares of Bio-Techne Corporation (TECH) in trading session dated Aug. 24, 2018. These shares are worth $942,350 and were traded at $188.47 each. The SEC filing shows that Higgins John L performed a sale of 10,000 shares. The Director disposed these shares by way of transaction on Aug. 23, 2018. The company’s shares were given away at $187.92 per share worth to an income of some $1,879,200 on account of Higgins John L.
Director, Dinarello Charles A, sold 5,000 common shares of Bio-Techne Corporation (TECH) in the open market. In a transaction dated Aug. 08, 2018, the shares were put up for sale at an average price of $176.94, raking in a sum of $884,700. After this sale, 8,212 common shares of TECH are directly owned by the insider, with total stake valued at $1,262,102.
In the transaction dated Jun. 07, 2018, the great number of shares disposed came courtesy the CEO; Kummeth Charles R. disposed a total of 8,000 shares at an average price of $160, amounting to approximately $1,280,000. The insider now directly owns 76,472 shares worth $11,752,982.Bio-Techne Corporation (TECH) Analyst Guide
Several analysts have released their opinion on Bio-Techne Corporation (NASDAQ:TECH), with 4 analysts believing it is a strong buy. Whereas 5 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.11 average brokerage recommendation.